Concepedia
Statistics
Publications
5
Citations
361
H-Index
Active since
2018
Affiliations
Erasmus MC Cancer Institute(Current)
Oncode Institute
Dora Hammerl is an author at Erasmus MC Cancer Institute specializing in oncology, medicine, and immunology.
Publications per year
2018–2024
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
Dora Hammerl, John W.M. Martens, Mieke Timmermans et al. · Nature Communications · 2021 · 251 citations · Full text
Medicine, Immunology, Oncology +17
Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes
Dora Hammerl, Maarten P.G. Massink, Marcel Smid et al. · Clinical Cancer Research · 2019 · 49 citations · Full text
Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer
Katharina Uhr, Anieta M. Sieuwerts, Vanja de Weerd et al. · Scientific Reports · 2018 · 35 citations · Full text
Medicine, Cancer Biology, Oncology +16
V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma
Pim Mutsaers, Hayri E. Balcıoğlu, Rowan Kuiper et al. · Cancers · 2021 · 15 citations · Full text
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
Dian Kortleve, Dora Hammerl, Mandy van Brakel et al. · Cancer Discovery · 2024 · 11 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 5